Market revenue in 2023 | USD 38.6 million |
Market revenue in 2030 | USD 74.5 million |
Growth rate | 9.8% (CAGR from 2023 to 2030) |
Largest segment | Transrectal |
Fastest growing segment | Transperineal |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Transrectal, Transperineal |
Key market players worldwide | Koninklijke Philips NV, Hitachi Ltd, Esaote, Eigen, MedCom, Koelis, Focal Healthcare, UC Care |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fusion biopsy market will help companies and investors design strategic landscapes.
Transrectal was the largest segment with a revenue share of 84.72% in 2023. Horizon Databook has segmented the UK fusion biopsy market based on transrectal, transperineal covering the revenue growth of each sub-segment from 2018 to 2030.
Prostate cancer is most common among men in the UK, with almost 40,000 new cases being diagnosed each year. The NHS is one of the largest medical service providers for prostate cancer diagnosis in the country.
In March 2018, the NHS announced its plans to adopt a new approach, called rapid pathway, to reduce the diagnosis time for prostate cancer from weeks to a one-day procedure. In line with this initiative, the organization started installing MRI units and fusion biopsy machines in a few hospitals within the UK.
They have planned to further extend this approach to more hospitals across the country, owing to positive outcomes. Such initiatives are expected to boost the demand for fusion imaging systems in the UK, driving the market.
Horizon Databook provides a detailed overview of country-level data and insights on the UK fusion biopsy market , including forecasts for subscribers. This country databook contains high-level insights into UK fusion biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account